Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $4.3M
Source: SeekingAlpha
2026-02-10 16:44:09 ET
More on Sonoma Pharmaceuticals
- Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
- Historical earnings data for Sonoma Pharmaceuticals
- Financial information for Sonoma Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $4.3M
Sonoma Pharmaceuticals Inc.
NASDAQ: SNOA
SNOA Trading
-8.73% G/L:
$2.4096 Last:
16,570 Volume:
$2.56 Open:
SNOA Latest News
February 10, 2026 04:10:00 pm
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
January 28, 2026 04:15:00 pm
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
November 13, 2025 08:30:00 am
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
SNOA Stock Data
$5,060,701
1,667,054
3.53%
11
N/A
Pharmaceuticals
Healthcare
US
Boulder
